Anita Krithivas Gandhi

5PUBLICATIONS
36CO-AUTHORS
Molecular targetsElectrometallurgyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 29, 2026
NSD2 Degradation Remediates the Oncogenic Cistrome in t(4;14) Multiple Myeloma.

|May 12, 2026
Mezigdomide reverses T-cell exhaustion through degradation of IKZF1/IKZF3 and reinvigoration of cytokine production pathways.

|May 08, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

|Oct 07, 2024
Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance.

Camille Laurent, Preeti Trisal, Bruno Tesson

|Feb 16, 2019
Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.

Hsiling Chiu, Preeti Trisal, Chad Bjorklund

Pageof 1

Frequent Collaborators

2 joint publications

Chad C Bjorklund

2 joint publications

Thomas A Milne

2 joint publications

Sarah Gooding

1 joint publications

Deborah S Mortensen